Orthofix Medical Inc. (OFIX) News
Filter OFIX News Items
OFIX News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
OFIX News Highlights
- For OFIX, its 30 day story count is now at 4.
- Over the past 16 days, the trend for OFIX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest OFIX News From Around the Web
Below are the latest news stories about ORTHOFIX MEDICAL INC that investors may wish to consider to help them evaluate OFIX as an investment opportunity.
Orthofix (OFIX) Releases New Data for Spinal Fusion ProceduresAccording to Orthofix (OFIX), this data highlights the noninvasive and cost-effective nature of SpinalStim, enabling patients to continue their healing in the comfort of their homes. |
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of PseudarthrosisLEWISVILLE, Texas, December 21, 2023--New data supports use of SpinalStim as adjunct therapy for patients at high risk of pseudarthrosis after lumbar spine fusion procedures. |
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics CompanyLEWISVILLE, Texas, December 12, 2023--Orthofix Medical Inc. (NASDAQ: OFIX) ("Orthofix" or the "Company") today announced the appointment of three new independent directors to the Company’s Board. These new directors bring substantial finance, strategic development, healthcare and medical technology experience to further advance Orthofix’s position as a leading global spine and orthopedics company. The appointments follow constructive engagement and entry into a cooperation agreement with Engine |
Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to TradeThe average of price targets set by Wall Street analysts indicates a potential upside of 72.2% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid- |
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical DiscLEWISVILLE, Texas, November 29, 2023--Five-year data for the M6-C artificial cervical disc published in The Spine Journal. M6-C and M6-L discs implantations reach 100,000 worldwide. |
Orthofix hires new CEO, 2 months after former leaders oustedMassimo Calafiore is expected to join the spine and orthopedic device maker in early 2024 from Italy-based LimaCorporate. |
Orthofix Names Massimo Calafiore as President and Chief Executive OfficerLEWISVILLE, Texas, November 28, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corpora |
Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View CutOrthofix (OFIX) saw very strong growth across multiple business segments and product lines in Q3. |
Does Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 78.7% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |